 postexposur prophylaxi zidovudin suppress human immunodefici viru type infect scid-hu mice time-depend manner occup exposur human immunodefici viru hiv low finit incid infect health care provid circumst postexposur administr zidovudin azt benefici possibl scid-hu mous immunodefici scid/scid mous human hematolymphoid organ azt differ time intraven infect standard dose hiv anim azt infect anim day suppress anim azt-sensit phase data support hypothesi prompt administr azt efficaci acut hiv infect human further studi scid-hu mous insight treatment protocol efficaci